iOncologi to acquire TargImmune to expand RNA-based immunotherapy for solid tumors

iOncologi, Inc., a clinical-stage biopharmaceutical company focused on immunotherapy, has announced the acquisition of TargImmune Therapeutics, a biotechnology firm specializing in tumor-targeted immunotherapies. This acquisition ... Read More